Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPS immunization with NF54 sporozoites followed by heterologous malaria challenge
NL-OMON41057Active, not recruiting
- Sponsor
- Nederlandse Vereniging voor Medische Microbiologie
- Start
- Feb 2015
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of chloroquine and Plasmodium falciparum sporozoites in malaria and Falciparum malaria (PF) (2 arms), sponsored by Nederlandse Vereniging voor Medische Microbiologie. Primary endpoint: Time to parasitemia after malaria challenge infection. Started Feb 2015; status: active, not recruiting.
02
Drugs
chloroquinePlasmodium falciparum sporozoites
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on NL-OMON41057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41057.